Japan market entry-arkiv - Biosector Ltd.

A man in a dark suit stands and points at a large projection screen with Japanese text and "LIFE SCIENCES LAB" graphics, inside a high-rise office overlooking the Tokyo skyline and Tokyo Tower. A seated audience, including people in lab coats, listens.

by Stefan Sandström

Japan Market Entry for Life Science Companies | Biosector

This article: Japan market entry can produce meetings, contacts and polite interest without producing commercial traction. […]

0

Editorial business illustration showing a giant wasp approaching a Takeda executive in a boardroom as dominoes labeled patent cliff, revenue erosion, cost savings, and workforce reduction begin to fall.

by Stefan Sandström

Takeda is Living the Japanese Proverb: “Wasp stings a crying eye”

The High Stakes of Innovation: Balancing Takeda’s $1.26B ‘Launch Machine’ and a $2.5B Antitrust Hit as […]

0

Illustration of a company at a crossroads choosing among three market access routes into Japan: Own MAH, 3rd party DMAH, or Japanese partner as MAH, shown as three numbered roads leading toward a Tokyo cityscape.

by Stefan Sandström

MAH, DMAH, or a Japanese Partner: A Strategic Choice You Need to Make Before Entering Japan

Entering Japan is not only about regulatory approval, launch planning, and commercial ambition. One of the […]

0

Photorealistic scene of a consultant in a Tokyo meeting room connecting a foreign company with Japanese pharma executives.

by Stefan Sandström

December 11, 2025

Why Japanese Targets Like You, Listen to You – and Still You Don’t Succeed

You fly in, you present, you charm the room. Heads nod. The technical team likes your […]

0

Abstract illustration representing Japan’s SaMD commercialization ecosystem.

by Stefan Sandström

SaMD Commercialization in Japan: Strategic Opportunities Beyond Approval

Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools […]

0